Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice
A total of 64 human HCC specimens (32 HCC with better prognosis or HCCB and 32 with poorer prognosis or HCCP) were analyzed for the activity of HSF1 (A), AKT (B), mTOR (C) using commercially available ELISA kits following the manufacturers' instructions. Of note, a significant, direct correlation was detected between the activity of HSF1 and that of AKT (D) and mTOR (E) in the same specimens. Student's t test: P < 0.0001 a, vs HCCB. HCCb, HCC with better outcome/longer survival (survival > 3 years following partial liver resection). b HCCp, HCC with poorer outcome/shorter survival (survival < 3 years following partial liver resection). 
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